ERBB2 and gastric cancer: Importantly, we provided indicators for these chemotherapy and targeted therapy, including MSI/MSS, ERBB2 expression, the activation of ECM and TCR signals, to help develop rational treatment options for GC patients in clinic, thus providing them more effective strategy.